pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-605 |
Genomic Coordinates | chr10: 51299573 - 51299655 |
Synonyms | MIRN605, hsa-mir-605, MIR605 |
Description | Homo sapiens miR-605 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-605-5p | ||||||||||||||||||||||||||||||||||||
Sequence | 16| UAAAUCCCAUGGUGCCUUCUCCU |38 | ||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||
Experiments | SAGE | ||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TRAF4 | ||||||||||||||||||||
Synonyms | CART1, MLN62, RNF83 | ||||||||||||||||||||
Description | TNF receptor associated factor 4 | ||||||||||||||||||||
Transcript | NM_004295 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TRAF4 | |||||||||||||||||||||
3'UTR of TRAF4 (miRNA target sites are highlighted) |
>TRAF4|NM_004295|3'UTR 1 GTGCAGGTGGGGTTCGAGGGGAAAGGACGATGGGGCATGACCTCAGTCAGGCACTGGCTGAACTTGGAGAGGGGGCCGGA 81 CCCCCGTCAGCTGCTTCTGCTGCCTAGGTTCTGTTACCCCATCCTCCCTCCCCCAGCCACCACCCTCAGGTGCCTCCAAT 161 TGGTGCTTCAGCCCTGGCCCCTGTGGGGAACAGGTCTTGGGGTCATGAAGGGCTGGAAACAAGTGACCCCAGGGCCTGTC 241 TCCCTTCTTGGGTAGGGCAGACATGCCTTGGTGCCGGTCACACTCTACACGGACTGAGGTGCCTGCTCAGGTGCTATGTC 321 CCAAGAGCCATAAGGGGGTGGGAATTGGGGAGGGAGAAAGGGTAGTTCAAAGAGTCTGTCTTGAGATCTGATTTTTTCCC 401 CCTTTACCTAGCTGTGCCCCCTCTGGTTATTTATTTCCTTAGTGCCAGGAGGGCACAGCAGGGGAGCCCTGATTTTTAAT 481 AAATCCGGAATTGTATTTATTAATTTGCTTCCAGCCTGACTTACCTGGGTTGGTTAGGTCCCTGGGAGGCTCAACCAAAC 561 TGAAGGCAAAGAAAGGACCAGTCAGAGAAGGGCCGCTGCCTGGGTCTGGCCCCAGGATCCAGCTTACCTGCTGGCTCGCC 641 CTCTGATGGACGCCGGGAAAACTGCATCGGGCTTTGTGTGGAAGACGGTCCCTGCCACTGCCCTCTGCCGATGAAATGCG 721 GGAAGTGTATGGCCTAGATGTTTCATAAGGCTGGAGTCCCTGGTCAGCCCCACCAGATTAGTGCTTCTACCCTAGGCAGG 801 GCTTTCTTGGTCTAATGGTAATAAGCACCGACACTGCTAAGCACTTTACGTGCATTATTATTTCATTGAAAAGAACTGTC 881 AAGTGAAATACTTTTTAGCACAGTAACTGGCTTTGTGGGCTCTAGAGAAGAGTTAATGAGGCAGTGCATGTTCTTGGCCC 961 AGAGTAAGTGCTTAGTGAATGCTTTCTAACTCCGAACCCCAGCCACATCCAGGGACTGGGTGTTGAGCAAAAGGGGCCTT 1041 CAAGATGTTCAAGGCACTTGGATTTTCTCCTGTCTCTCATCGGCTTTTCTTAACGGGCCTCAGTGGGTGCATGTGATTAT 1121 CCACGTTTCACCTATGAAACATGAACAGAGGAGACTGACTTATCAGTGATTCTTCCGCGGGTTCGGACAGGGCCTCGATT 1201 CTGTTTTAAACTCCAGTAGTCCCTAGAAATTGTAGCTCCCTCTAGTTGTGGCAATAGGTGTGGGTCCTTGTGCTTGCTTT 1281 TGGCAAGTTTCTGAGCTACACAGGGCCTCCATTACCGTCACTGGTGAAATGCGGCTCACCTCCCAGATTTGTTGTAAAGA 1361 TTAAATGAACTGGTCAGCACA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Flp-In T-REx 293-hAGO1 cells |
Location of target site | 3'UTR |
Original Description (Extracted from the article) |
...
Validation of interactions identified by CLASH suppports their reliability.
... - Helwak A; Kudla G; Dudnakova T; Tollervey D, 2013, Cell. |
Article |
- Helwak A; Kudla G; Dudnakova T; Tollervey D - Cell, 2013
MicroRNAs (miRNAs) play key roles in gene regulation, but reliable bioinformatic or experimental identification of their targets remains difficult. To provide an unbiased view of human miRNA targets, we developed a technique for ligation and sequencing of miRNA-target RNA duplexes associated with human AGO1. Here, we report data sets of more than 18,000 high-confidence miRNA-mRNA interactions. The binding of most miRNAs includes the 5' seed region, but around 60% of seed interactions are noncanonical, containing bulged or mismatched nucleotides. Moreover, seed interactions are generally accompanied by specific, nonseed base pairing. 18% of miRNA-mRNA interactions involve the miRNA 3' end, with little evidence for 5' contacts, and some of these were functionally validated. Analyses of miRNA:mRNA base pairing showed that miRNA species systematically differ in their target RNA interactions, and strongly overrepresented motifs were found in the interaction sites of several miRNAs. We speculate that these affect the response of RISC to miRNA-target binding.
LinkOut: [PMID: 23622248]
|
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
107 hsa-miR-605-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT001230 | SEC24D | SEC24 homolog D, COPII coat complex component | 3 | 1 | ||||||||
MIRT016155 | TP53 | tumor protein p53 | 2 | 1 | ||||||||
MIRT016156 | TCEAL1 | transcription elongation factor A like 1 | 1 | 1 | ||||||||
MIRT016157 | MDM2 | MDM2 proto-oncogene | 2 | 1 | ||||||||
MIRT040476 | YBX1 | Y-box binding protein 1 | 1 | 1 | ||||||||
MIRT040477 | TMEM64 | transmembrane protein 64 | 1 | 1 | ||||||||
MIRT040478 | KDM5C | lysine demethylase 5C | 1 | 1 | ||||||||
MIRT040479 | TRAF4 | TNF receptor associated factor 4 | 1 | 1 | ||||||||
MIRT040480 | DRG1 | developmentally regulated GTP binding protein 1 | 1 | 1 | ||||||||
MIRT040481 | BCL9 | B-cell CLL/lymphoma 9 | 1 | 1 | ||||||||
MIRT055125 | SCD | stearoyl-CoA desaturase | 2 | 2 | ||||||||
MIRT057521 | CEP55 | centrosomal protein 55 | 2 | 2 | ||||||||
MIRT081129 | LDLR | low density lipoprotein receptor | 2 | 6 | ||||||||
MIRT096817 | ZSWIM6 | zinc finger SWIM-type containing 6 | 2 | 4 | ||||||||
MIRT100961 | CENPQ | centromere protein Q | 2 | 4 | ||||||||
MIRT263338 | ANAPC16 | anaphase promoting complex subunit 16 | 2 | 2 | ||||||||
MIRT274710 | CPSF6 | cleavage and polyadenylation specific factor 6 | 2 | 2 | ||||||||
MIRT311193 | ANKRD33B | ankyrin repeat domain 33B | 2 | 2 | ||||||||
MIRT360127 | DEK | DEK proto-oncogene | 2 | 2 | ||||||||
MIRT438269 | PSMD10 | proteasome 26S subunit, non-ATPase 10 | 2 | 1 | ||||||||
MIRT442464 | SLC25A13 | solute carrier family 25 member 13 | 2 | 2 | ||||||||
MIRT446110 | TSC22D2 | TSC22 domain family member 2 | 2 | 2 | ||||||||
MIRT463119 | ZNF507 | zinc finger protein 507 | 2 | 2 | ||||||||
MIRT470566 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT475059 | IVNS1ABP | influenza virus NS1A binding protein | 2 | 6 | ||||||||
MIRT482538 | ACTB | actin beta | 2 | 4 | ||||||||
MIRT494136 | DCAF7 | DDB1 and CUL4 associated factor 7 | 2 | 6 | ||||||||
MIRT495209 | EDN3 | endothelin 3 | 2 | 2 | ||||||||
MIRT495235 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | 2 | 2 | ||||||||
MIRT496762 | MANBAL | mannosidase beta like | 2 | 2 | ||||||||
MIRT498885 | ZNF12 | zinc finger protein 12 | 2 | 10 | ||||||||
MIRT499280 | NBPF11 | NBPF member 11 | 2 | 2 | ||||||||
MIRT507063 | H3F3B | H3 histone family member 3B | 2 | 2 | ||||||||
MIRT508352 | HES7 | hes family bHLH transcription factor 7 | 2 | 8 | ||||||||
MIRT510740 | SMC1A | structural maintenance of chromosomes 1A | 2 | 6 | ||||||||
MIRT519872 | ZFP62 | ZFP62 zinc finger protein | 2 | 4 | ||||||||
MIRT521272 | RTN4 | reticulon 4 | 2 | 4 | ||||||||
MIRT522324 | NFIB | nuclear factor I B | 2 | 6 | ||||||||
MIRT525011 | ACTN4 | actinin alpha 4 | 2 | 6 | ||||||||
MIRT526608 | AASDH | aminoadipate-semialdehyde dehydrogenase | 2 | 4 | ||||||||
MIRT529043 | ARL9 | ADP ribosylation factor like GTPase 9 | 2 | 2 | ||||||||
MIRT529545 | ZNF678 | zinc finger protein 678 | 2 | 2 | ||||||||
MIRT532500 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT532599 | SIX4 | SIX homeobox 4 | 2 | 2 | ||||||||
MIRT534044 | STK4 | serine/threonine kinase 4 | 2 | 2 | ||||||||
MIRT534087 | SPPL3 | signal peptide peptidase like 3 | 2 | 2 | ||||||||
MIRT534249 | SLC16A1 | solute carrier family 16 member 1 | 2 | 2 | ||||||||
MIRT534286 | SLC12A7 | solute carrier family 12 member 7 | 2 | 2 | ||||||||
MIRT534555 | RUNX1 | runt related transcription factor 1 | 2 | 2 | ||||||||
MIRT536765 | HOXB2 | homeobox B2 | 2 | 2 | ||||||||
MIRT537227 | GAN | gigaxonin | 2 | 2 | ||||||||
MIRT551105 | TTC8 | tetratricopeptide repeat domain 8 | 2 | 2 | ||||||||
MIRT552247 | DUSP3 | dual specificity phosphatase 3 | 2 | 2 | ||||||||
MIRT554361 | SFXN5 | sideroflexin 5 | 2 | 2 | ||||||||
MIRT557402 | H3F3C | H3 histone family member 3C | 2 | 2 | ||||||||
MIRT559116 | C16orf52 | chromosome 16 open reading frame 52 | 2 | 2 | ||||||||
MIRT560494 | BUB3 | BUB3, mitotic checkpoint protein | 2 | 2 | ||||||||
MIRT562296 | GLO1 | glyoxalase I | 2 | 2 | ||||||||
MIRT562597 | CAPZA2 | capping actin protein of muscle Z-line alpha subunit 2 | 2 | 2 | ||||||||
MIRT563857 | ALYREF | Aly/REF export factor | 2 | 4 | ||||||||
MIRT565665 | SIX1 | SIX homeobox 1 | 2 | 2 | ||||||||
MIRT568253 | BTF3L4 | basic transcription factor 3 like 4 | 2 | 2 | ||||||||
MIRT609593 | GPM6B | glycoprotein M6B | 2 | 2 | ||||||||
MIRT611552 | GGT6 | gamma-glutamyltransferase 6 | 2 | 2 | ||||||||
MIRT613451 | CYLD | CYLD lysine 63 deubiquitinase | 2 | 2 | ||||||||
MIRT615516 | PRRC2A | proline rich coiled-coil 2A | 2 | 2 | ||||||||
MIRT617766 | C17orf105 | chromosome 17 open reading frame 105 | 2 | 2 | ||||||||
MIRT619134 | MCOLN3 | mucolipin 3 | 2 | 2 | ||||||||
MIRT621365 | CAP2 | cyclase associated actin cytoskeleton regulatory protein 2 | 2 | 2 | ||||||||
MIRT625804 | MDC1 | mediator of DNA damage checkpoint 1 | 2 | 2 | ||||||||
MIRT626954 | PRDM2 | PR/SET domain 2 | 2 | 2 | ||||||||
MIRT627716 | RCAN1 | regulator of calcineurin 1 | 2 | 2 | ||||||||
MIRT628069 | KCNJ13 | potassium voltage-gated channel subfamily J member 13 | 2 | 2 | ||||||||
MIRT630451 | GTPBP8 | GTP binding protein 8 (putative) | 2 | 2 | ||||||||
MIRT635533 | ELMOD2 | ELMO domain containing 2 | 2 | 2 | ||||||||
MIRT636206 | SULF2 | sulfatase 2 | 2 | 2 | ||||||||
MIRT638763 | EPHA4 | EPH receptor A4 | 2 | 2 | ||||||||
MIRT640324 | STAT1 | signal transducer and activator of transcription 1 | 2 | 2 | ||||||||
MIRT644548 | SPOP | speckle type BTB/POZ protein | 2 | 2 | ||||||||
MIRT645114 | TMX2 | thioredoxin related transmembrane protein 2 | 2 | 2 | ||||||||
MIRT647778 | NANOS1 | nanos C2HC-type zinc finger 1 | 2 | 2 | ||||||||
MIRT650112 | ZCCHC9 | zinc finger CCHC-type containing 9 | 2 | 2 | ||||||||
MIRT650136 | ABCB7 | ATP binding cassette subfamily B member 7 | 2 | 2 | ||||||||
MIRT650310 | SLC35E2 | solute carrier family 35 member E2 | 2 | 2 | ||||||||
MIRT650930 | ST6GALNAC1 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | 2 | 2 | ||||||||
MIRT651018 | ZNF740 | zinc finger protein 740 | 2 | 2 | ||||||||
MIRT653541 | SLC38A9 | solute carrier family 38 member 9 | 2 | 2 | ||||||||
MIRT655752 | NR2C2 | nuclear receptor subfamily 2 group C member 2 | 2 | 2 | ||||||||
MIRT656908 | KIAA1958 | KIAA1958 | 2 | 2 | ||||||||
MIRT657854 | GJD3 | gap junction protein delta 3 | 2 | 2 | ||||||||
MIRT658215 | FBXO21 | F-box protein 21 | 2 | 2 | ||||||||
MIRT659884 | CAPN7 | calpain 7 | 2 | 2 | ||||||||
MIRT659922 | CACNA1E | calcium voltage-gated channel subunit alpha1 E | 2 | 2 | ||||||||
MIRT660055 | C12orf5 | TP53 induced glycolysis regulatory phosphatase | 1 | 1 | ||||||||
MIRT664616 | LIMD1 | LIM domains containing 1 | 2 | 2 | ||||||||
MIRT665392 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 2 | ||||||||
MIRT667887 | IP6K1 | inositol hexakisphosphate kinase 1 | 2 | 2 | ||||||||
MIRT669018 | CHORDC1 | cysteine and histidine rich domain containing 1 | 2 | 2 | ||||||||
MIRT688419 | DUSP2 | dual specificity phosphatase 2 | 2 | 2 | ||||||||
MIRT691888 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT709530 | GEN1 | GEN1, Holliday junction 5' flap endonuclease | 2 | 2 | ||||||||
MIRT711013 | ABCD2 | ATP binding cassette subfamily D member 2 | 2 | 2 | ||||||||
MIRT714731 | CENPH | centromere protein H | 2 | 2 | ||||||||
MIRT719897 | PTGIS | prostaglandin I2 synthase | 2 | 2 | ||||||||
MIRT725028 | CX3CL1 | C-X3-C motif chemokine ligand 1 | 2 | 2 | ||||||||
MIRT734348 | P2RY12 | purinergic receptor P2Y12 | 3 | 0 | ||||||||
MIRT736719 | TNFAIP3 | TNF alpha induced protein 3 | 3 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|